These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

768 related articles for article (PubMed ID: 8929531)

  • 1. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L).
    Zha J; Harada H; Yang E; Jockel J; Korsmeyer SJ
    Cell; 1996 Nov; 87(4):619-28. PubMed ID: 8929531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival-factor-induced phosphorylation of Bad results in its dissociation from Bcl-x(L) but not Bcl-2.
    Hirai I; Wang HG
    Biochem J; 2001 Oct; 359(Pt 2):345-52. PubMed ID: 11583580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p21-activated kinase 1 phosphorylates the death agonist bad and protects cells from apoptosis.
    Schürmann A; Mooney AF; Sanders LC; Sells MA; Wang HG; Reed JC; Bokoch GM
    Mol Cell Biol; 2000 Jan; 20(2):453-61. PubMed ID: 10611223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation.
    Datta SR; Katsov A; Hu L; Petros A; Fesik SW; Yaffe MB; Greenberg ME
    Mol Cell; 2000 Jul; 6(1):41-51. PubMed ID: 10949026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAD Ser-155 phosphorylation regulates BAD/Bcl-XL interaction and cell survival.
    Tan Y; Demeter MR; Ruan H; Comb MJ
    J Biol Chem; 2000 Aug; 275(33):25865-9. PubMed ID: 10837486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Bcl-2-associated death protein and counter-response of Akt within cell populations during seizure-induced neuronal death.
    Henshall DC; Araki T; Schindler CK; Lan JQ; Tiekoter KL; Taki W; Simon RP
    J Neurosci; 2002 Oct; 22(19):8458-65. PubMed ID: 12351720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt.
    del Peso L; González-García M; Page C; Herrera R; Nuñez G
    Science; 1997 Oct; 278(5338):687-9. PubMed ID: 9381178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155.
    Zhou XM; Liu Y; Payne G; Lutz RJ; Chittenden T
    J Biol Chem; 2000 Aug; 275(32):25046-51. PubMed ID: 10837473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155.
    Lizcano JM; Morrice N; Cohen P
    Biochem J; 2000 Jul; 349(Pt 2):547-57. PubMed ID: 10880354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity.
    Zha J; Harada H; Osipov K; Jockel J; Waksman G; Korsmeyer SJ
    J Biol Chem; 1997 Sep; 272(39):24101-4. PubMed ID: 9305851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Underphosphorylated BAD interacts with diverse antiapoptotic Bcl-2 family proteins to regulate apoptosis.
    Bae J; Hsu SY; Leo CP; Zell K; Hsueh AJ
    Apoptosis; 2001 Oct; 6(5):319-30. PubMed ID: 11483855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein phosphatase 2A activates the proapoptotic function of BAD in interleukin- 3-dependent lymphoid cells by a mechanism requiring 14-3-3 dissociation.
    Chiang CW; Harris G; Ellig C; Masters SC; Subramanian R; Shenolikar S; Wadzinski BE; Yang E
    Blood; 2001 Mar; 97(5):1289-97. PubMed ID: 11222372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase.
    Scheid MP; Schubert KM; Duronio V
    J Biol Chem; 1999 Oct; 274(43):31108-13. PubMed ID: 10521512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD.
    Wang HG; Pathan N; Ethell IM; Krajewski S; Yamaguchi Y; Shibasaki F; McKeon F; Bobo T; Franke TF; Reed JC
    Science; 1999 Apr; 284(5412):339-43. PubMed ID: 10195903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins.
    Ottilie S; Diaz JL; Horne W; Chang J; Wang Y; Wilson G; Chang S; Weeks S; Fritz LC; Oltersdorf T
    J Biol Chem; 1997 Dec; 272(49):30866-72. PubMed ID: 9388232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.
    Datta SR; Dudek H; Tao X; Masters S; Fu H; Gotoh Y; Greenberg ME
    Cell; 1997 Oct; 91(2):231-41. PubMed ID: 9346240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How BAD phosphorylation is good for survival.
    Downward J
    Nat Cell Biol; 1999 Jun; 1(2):E33-5. PubMed ID: 10559890
    [No Abstract]   [Full Text] [Related]  

  • 18. Interleukin-7 inactivates the pro-apoptotic protein Bad promoting T cell survival.
    Li WQ; Jiang Q; Khaled AR; Keller JR; Durum SK
    J Biol Chem; 2004 Jul; 279(28):29160-6. PubMed ID: 15123689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BID: a novel BH3 domain-only death agonist.
    Wang K; Yin XM; Chao DT; Milliman CL; Korsmeyer SJ
    Genes Dev; 1996 Nov; 10(22):2859-69. PubMed ID: 8918887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The FLT3 internal tandem duplication mutation prevents apoptosis in interleukin-3-deprived BaF3 cells due to protein kinase A and ribosomal S6 kinase 1-mediated BAD phosphorylation at serine 112.
    Yang X; Liu L; Sternberg D; Tang L; Galinsky I; DeAngelo D; Stone R
    Cancer Res; 2005 Aug; 65(16):7338-47. PubMed ID: 16103085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.